Benchmarking schizophrenia with a focus on pharmacotherapy and metabolic syndrome

被引：0
|
作者：
Prescott, J. [1 ]
机构：
[1] MCM Grp, Marlton, NJ USA
来源：
VALUE IN HEALTH | 2008年 / 11卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)70352-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A109 / A109
页数：1
相关论文
共 50 条
  • [1] Pharmacotherapy of metabolic complications of schizophrenia
    Jafari, M
    Casey, DE
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 563 - 564
  • [2] Pharmacotherapy for the Metabolic Syndrome
    Swislocki, Arthur L. M.
    Siegel, David
    Jialal, Ishwarlal
    CURRENT VASCULAR PHARMACOLOGY, 2012, 10 (02) : 187 - 205
  • [3] Pharmacotherapy of metabolic syndrome
    Radisavljevic, N.
    Dimitrijevic, D.
    SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 118S - 118S
  • [4] Management of Schizophrenia in Children and Adolescents Focus on Pharmacotherapy
    Masi, Gabriele
    Liboni, Francesca
    DRUGS, 2011, 71 (02) : 179 - 208
  • [5] Symptomatic versus metabolic changes with pharmacotherapy of schizophrenia
    Small, JG
    Klapper, MH
    Malloy, FW
    Medlock, CE
    Kellams, JJ
    SCHIZOPHRENIA RESEARCH, 2005, 75 (2-3) : 449 - 451
  • [6] METABOLIC SYNDROME - SIGNIFICANCE FOR PHARMACOTHERAPY OF HYPERTENSION
    SCHREY, A
    HERZ KREISLAUF, 1994, 26 (09): : R3 - +
  • [7] Pharmacotherapy of Mixed Dyslipidemia in the Metabolic Syndrome
    Nakajima, Kei
    CURRENT CLINICAL PHARMACOLOGY, 2010, 5 (02): : 133 - 139
  • [8] Focus on Pharmacotherapy for Irritable Bowel Syndrome with Constipation
    Liu, Joy J.
    Brenner, Darren M.
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2021, 50 (03) : 639 - 653
  • [9] Metabolic syndrome and schizophrenia
    Thakore, JH
    BRITISH JOURNAL OF PSYCHIATRY, 2005, 186 : 455 - 456
  • [10] The metabolic syndrome and schizophrenia
    Meyer, J. M.
    Stahl, S. M.
    ACTA PSYCHIATRICA SCANDINAVICA, 2009, 119 (01) : 4 - 14
12345